Literature DB >> 2324497

In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins.

K J Hamann1, G J Gleich, J L Checkel, D A Loegering, J W McCall, R L Barker.   

Abstract

Eosinophil infiltration and degranulation around the tissue-invasive stages of several species of helminths have been observed. Release of eosinophil granule contents upon the worms is supported by localization of two of the major granule proteins, major basic protein (MBP) and eosinophil peroxidase (EPO), on and around species of trematodes, nematodes, and cestodes. In the case of filarial worms, MBP is deposited on degenerating microfilariae (mf) of Onchocerca volvulus. Here, we performed in vitro assays of the toxicity of four purified eosinophil granule proteins, namely, MBP, EPO, eosinophil cationic protein (ECP), and eosinophil-derived neurotoxin (EDN), for the mf of Brugia pahangi and Brugia malayi. MBP, ECP, and EDN killed these worms in a dose-related manner although relatively high concentrations of EDN were necessary. EPO, in the presence of a H2O2-generating system and a halide, was the most potent toxin on a molar basis; here, the most potent halide was I- followed by Br- and Cl-. Surprisingly, EPO in the absence of H2O2 killed mf at concentrations comparable to those required for MBP and ECP. The toxicity of EPO + H2O2 + halide was inhibited by heparin, catalase, or 1% BSA, whereas the toxicity of EPO alone was inhibited only by heparin. Heparin also inhibited killing by both MBP and ECP. Despite the homology of ECP with certain RNases, placental RNasin, an RNase inhibitor, was unable to inhibit ECP-mediated toxicity. These results indicate that all of the eosinophil granule proteins are toxic to mf and they support the hypothesis that eosinophil degranulation causes death of mf in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2324497

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

Review 1.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

2.  Identification of the major soluble cuticular glycoprotein of lymphatic filarial nematode parasites (gp29) as a secretory homolog of glutathione peroxidase.

Authors:  E Cookson; M L Blaxter; M E Selkirk
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

Review 3.  RNase A ribonucleases and host defense: an evolving story.

Authors:  Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2008-01-22       Impact factor: 4.962

4.  Eosinophils, but not eosinophil peroxidase or major basic protein, are important for host protection in experimental Brugia pahangi infection.

Authors:  Thirumalai Ramalingam; Patricia Porte; James Lee; T V Rajan
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  Antimicrobial Activity of Human Eosinophil Granule Proteins.

Authors:  Anu Chopra; Janendra K Batra
Journal:  Methods Mol Biol       Date:  2021

6.  Alternatively Activated Macrophages Revisited: New Insights into the Regulation of Immunity, Inflammation and Metabolic Function following Parasite Infection.

Authors:  Jessica C Jang; Meera G Nair
Journal:  Curr Immunol Rev       Date:  2013-08-01

Review 7.  Nematodes and the spleen: an immunological relationship.

Authors:  J L John
Journal:  Experientia       Date:  1994-01-15

8.  The Effect of Helminths on Granulocyte Activation: A Cluster-Randomized Placebo-Controlled Trial in Indonesia.

Authors:  Karin de Ruiter; Dicky L Tahapary; Erliyani Sartono; Thomas B Nutman; Johannes W A Smit; Leo Koenderman; Taniawati Supali; Maria Yazdanbakhsh
Journal:  J Infect Dis       Date:  2019-04-16       Impact factor: 5.226

Review 9.  Eosinophil granule proteins: form and function.

Authors:  K Ravi Acharya; Steven J Ackerman
Journal:  J Biol Chem       Date:  2014-05-06       Impact factor: 5.157

Review 10.  Eosinophil-derived neurotoxin / RNase 2: connecting the past, the present and the future.

Authors:  H F Rosenberg
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.